# Radiation Use During Vemurafenib Treatment

> **NCT01843738** · PHASE1 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- BRAFV600 Mutation
- Stage IV Melanoma

## Interventions

- **RADIATION:** Radiation therapy
- **DRUG:** Vemurafenib

## Key facts

- **NCT ID:** NCT01843738
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-06
- **Primary completion:** 2022-08
- **Final completion:** 2022-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Competing Trials
- **Last updated:** 2017-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01843738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01843738, "Radiation Use During Vemurafenib Treatment". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01843738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*